Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes.

Blum WF, Klammt J, Amselem S, Pfäffle HM, Legendre M, Sobrier ML, Luton MP, Child CJ, Jones C, Zimmermann AG, Quigley CA, Cutler GB Jr, Deal CL, Lebl J, Rosenfeld RG, Parks JS, Pfäffle RW.

EBioMedicine. 2018 Oct;36:390-400. doi: 10.1016/j.ebiom.2018.09.026. Epub 2018 Sep 25. No abstract available.

2.

Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.

Child CJ, Zimmermann AG, Chrousos GP, Cummings E, Deal CL, Hasegawa T, Jia N, Lawrence S, Linglart A, Loche S, Maghnie M, Pérez Sánchez J, Polak M, Predieri B, Richter-Unruh A, Rosenfeld RG, Yeste D, Yorifuji T, Blum WF.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):379-389. doi: 10.1210/jc.2018-01189.

3.

Chitayat-Hall and Schaaf-Yang syndromes:a common aetiology: expanding the phenotype of MAGEL2-related disorders.

Jobling R, Stavropoulos DJ, Marshall CR, Cytrynbaum C, Axford MM, Londero V, Moalem S, Orr J, Rossignol F, Lopes FD, Gauthier J, Alos N, Rupps R, McKinnon M, Adam S, Nowaczyk MJM, Walker S, Scherer SW, Nassif C, Hamdan FF, Deal CL, Soucy JF, Weksberg R, Macleod P, Michaud JL, Chitayat D.

J Med Genet. 2018 May;55(5):316-321. doi: 10.1136/jmedgenet-2017-105222. Epub 2018 Mar 29.

PMID:
29599419
4.

Genetic variations at the human growth hormone receptor (GHR) gene locus are associated with idiopathic short stature.

Dias C, Giordano M, Frechette R, Bellone S, Polychronakos C, Legault L, Deal CL, Goodyer CG.

J Cell Mol Med. 2017 Nov;21(11):2985-2999. doi: 10.1111/jcmm.13210. Epub 2017 May 29.

5.

Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial.

Benabbad I, Rosilio M, Child CJ, Carel JC, Ross JL, Deal CL, Drop SL, Zimmermann AG, Jia N, Quigley CA, Blum WF.

Horm Res Paediatr. 2017;87(1):42-50. doi: 10.1159/000452973. Epub 2016 Dec 22.

7.

DXA Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal Women.

Overman RA, Farley JF, Curtis JR, Zhang J, Gourlay ML, Deal CL.

J Clin Densitom. 2015 Apr-Jun;18(2):145-9. doi: 10.1016/j.jocd.2015.01.005. Epub 2015 Feb 18.

8.

Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis.

Overman RA, Gourlay ML, Deal CL, Farley JF, Brookhart MA, Layton JB.

Osteoporos Int. 2015 May;26(5):1515-24. doi: 10.1007/s00198-014-3022-9. Epub 2015 Jan 20.

9.

Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with Leigh syndrome.

Schwartzentruber J, Buhas D, Majewski J, Sasarman F, Papillon-Cavanagh S, Thiffault I, Sheldon KM, Massicotte C, Patry L, Simon M, Zare AS, McKernan KJ; FORGE Canada Consortium, Michaud J, Boles RG, Deal CL, Desilets V, Shoubridge EA, Samuels ME.

Hum Mutat. 2014 Nov;35(11):1285-9. doi: 10.1002/humu.22629. Epub 2014 Oct 18. Erratum in: Hum Mutat. 2015 Feb;36(2):281. Thiffaut, Isabelle [corrected to Thiffault, Isabelle].

PMID:
25130867
10.

Empathy, autistic traits, and motor resonance in adults with Turner syndrome.

Lepage JF, Lortie M, Deal CL, Théoret H.

Soc Neurosci. 2014;9(6):601-9. doi: 10.1080/17470919.2014.944317. Epub 2014 Jul 31.

PMID:
25079009
11.

Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.

de Kock L, Sabbaghian N, Plourde F, Srivastava A, Weber E, Bouron-Dal Soglio D, Hamel N, Choi JH, Park SH, Deal CL, Kelsey MM, Dishop MK, Esbenshade A, Kuttesch JF, Jacques TS, Perry A, Leichter H, Maeder P, Brundler MA, Warner J, Neal J, Zacharin M, Korbonits M, Cole T, Traunecker H, McLean TW, Rotondo F, Lepage P, Albrecht S, Horvath E, Kovacs K, Priest JR, Foulkes WD.

Acta Neuropathol. 2014 Jul;128(1):111-22. doi: 10.1007/s00401-014-1285-z. Epub 2014 May 20.

12.

Cortical thickness correlates of socioemotional difficulties in adults with Turner syndrome.

Lepage JF, Clouchoux C, Lassonde M, Evans AC, Deal CL, Théoret H.

Psychoneuroendocrinology. 2014 Jun;44:30-4. doi: 10.1016/j.psyneuen.2014.02.017. Epub 2014 Mar 3.

PMID:
24767617
13.

United States adults meeting 2010 American College of Rheumatology criteria for treatment and prevention of glucocorticoid-induced osteoporosis.

Overman RA, Toliver JC, Yeh JY, Gourlay ML, Deal CL.

Arthritis Care Res (Hoboken). 2014 Nov;66(11):1644-52. doi: 10.1002/acr.22346.

14.

Exploring the association Between DICER1 mutations and differentiated thyroid carcinoma.

de Kock L, Sabbaghian N, Soglio DB, Guillerman RP, Park BK, Chami R, Deal CL, Priest JR, Foulkes WD.

J Clin Endocrinol Metab. 2014 Jun;99(6):E1072-7. doi: 10.1210/jc.2013-4206. Epub 2014 Mar 11.

PMID:
24617712
15.

Whole-exome sequencing: opportunities in pediatric endocrinology.

Samuels ME, Hasselmann C, Deal CL, Deladoey J, Vliet GV.

Per Med. 2014 Jan;11(1):63-78. doi: 10.2217/pme.13.96.

PMID:
29751389
16.

The regional distribution of rheumatologists: what can we do, what should we do?

Deal CL.

Arthritis Rheum. 2013 Dec;65(12):3011-3. doi: 10.1002/art.38169. No abstract available.

17.

50 years ago in the Journal of Pediatrics: autoimmune disorders of endocrine glands.

Deal CL, Rogol AD.

J Pediatr. 2013 Dec;163(6):1669. doi: 10.1016/j.jpeds.2013.06.001. No abstract available.

PMID:
24274204
18.

The Official Positions of the International Society for Clinical Densitometry: vertebral fracture assessment.

Rosen HN, Vokes TJ, Malabanan AO, Deal CL, Alele JD, Olenginski TP, Schousboe JT.

J Clin Densitom. 2013 Oct-Dec;16(4):482-8. doi: 10.1016/j.jocd.2013.08.003. Epub 2013 Sep 22. Review.

PMID:
24063846
19.

Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 Official Positions.

Malabanan AO, Rosen HN, Vokes TJ, Deal CL, Alele JD, Olenginski TP, Schousboe JT.

J Clin Densitom. 2013 Oct-Dec;16(4):467-71. doi: 10.1016/j.jocd.2013.08.002. Epub 2013 Sep 20. Review.

PMID:
24055260
20.

GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS; 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants.

J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87. doi: 10.1210/jc.2012-3888. Epub 2013 Mar 29. Review.

21.

A search for variables predicting cortisol response to low-dose corticotropin stimulation following supraphysiological doses of glucocorticoids.

Wildi-Runge S, Deladoëy J, Bélanger C, Deal CL, Van Vliet G, Alos N, Huot C.

J Pediatr. 2013 Aug;163(2):484-8. doi: 10.1016/j.jpeds.2013.01.011. Epub 2013 Feb 12.

PMID:
23414662
22.

Recent recommendations on steroid-induced osteoporosis: more targeted, but more complicated.

Deal CL.

Cleve Clin J Med. 2013 Feb;80(2):117-25. doi: 10.3949/ccjm.80a.11094.

PMID:
23376917
23.

Bioinactive ACTH causing glucocorticoid deficiency.

Samuels ME, Gallo-Payet N, Pinard S, Hasselmann C, Magne F, Patry L, Chouinard L, Schwartzentruber J, René P, Sawyer N, Bouvier M, Djemli A, Delvin E, Huot C, Eugene D, Deal CL, Van Vliet G, Majewski J, Deladoëy J; FORGE Canada Consortium.

J Clin Endocrinol Metab. 2013 Feb;98(2):736-42. doi: 10.1210/jc.2012-3199. Epub 2013 Jan 4.

PMID:
23293326
24.

Meier-Gorlin syndrome: growth and secondary sexual development of a microcephalic primordial dwarfism disorder.

de Munnik SA, Otten BJ, Schoots J, Bicknell LS, Aftimos S, Al-Aama JY, van Bever Y, Bober MB, Borm GF, Clayton-Smith J, Deal CL, Edrees AY, Feingold M, Fryer A, van Hagen JM, Hennekam RC, Jansweijer MC, Johnson D, Kant SG, Opitz JM, Ramadevi AR, Reardon W, Ross A, Sarda P, Schrander-Stumpel CT, Sluiter AE, Temple IK, Terhal PA, Toutain A, Wise CA, Wright M, Skidmore DL, Samuels ME, Hoefsloot LH, Knoers NV, Brunner HG, Jackson AP, Bongers EM.

Am J Med Genet A. 2012 Nov;158A(11):2733-42. doi: 10.1002/ajmg.a.35681. Epub 2012 Sep 28.

PMID:
23023959
25.

Prevalence of oral glucocorticoid usage in the United States: a general population perspective.

Overman RA, Yeh JY, Deal CL.

Arthritis Care Res (Hoboken). 2013 Feb;65(2):294-8. doi: 10.1002/acr.21796.

26.

46, XY gonadal dysgenesis: new SRY point mutation in two siblings with paternal germ line mosaicism.

Stoppa-Vaucher S, Ayabe T, Paquette J, Patey N, Francoeur D, Vuissoz JM, Deladoëy J, Samuels ME, Ogata T, Deal CL.

Clin Genet. 2012 Dec;82(6):505-13. doi: 10.1111/j.1399-0004.2011.01832.x. Epub 2012 Jan 30.

PMID:
22288726
27.

Abnormal motor cortex excitability is associated with reduced cortical thickness in X monosomy.

Lepage JF, Clouchoux C, Lassonde M, Evans AC, Deal CL, Théoret H.

Hum Brain Mapp. 2013 Apr;34(4):936-44. doi: 10.1002/hbm.21481. Epub 2011 Nov 18.

PMID:
22102524
28.

Child health, developmental plasticity, and epigenetic programming.

Hochberg Z, Feil R, Constancia M, Fraga M, Junien C, Carel JC, Boileau P, Le Bouc Y, Deal CL, Lillycrop K, Scharfmann R, Sheppard A, Skinner M, Szyf M, Waterland RA, Waxman DJ, Whitelaw E, Ong K, Albertsson-Wikland K.

Endocr Rev. 2011 Apr;32(2):159-224. doi: 10.1210/er.2009-0039. Epub 2010 Oct 22. Review.

29.

Risk of autoimmune diabetes in APECED: association with short alleles of the 5'insulin VNTR.

Paquette J, Varin DS, Hamelin CE, Hallgren A, Kämpe O, Carel JC, Perheentupa J, Deal CL.

Genes Immun. 2010 Oct;11(7):590-7. doi: 10.1038/gene.2010.33. Epub 2010 Jun 10.

PMID:
20535137
30.

A 21-year-old man with Still's disease with fever, rash, and pancytopenia.

Mehta BM, Hashkes PJ, Avery R, Deal CL.

Arthritis Care Res (Hoboken). 2010 Apr;62(4):575-9. doi: 10.1002/acr.20001. No abstract available.

31.

Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.

van der Kaay DC, Hendriks AE, Ester WA, Leunissen RW, Willemsen RH, de Kort SW, Paquette JR, Hokken-Koelega AC, Deal CL.

Growth Horm IGF Res. 2009 Jun;19(3):198-205. doi: 10.1016/j.ghir.2008.08.010. Epub 2008 Oct 16.

PMID:
18929499
32.

Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.

Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM; 2007 ISS Consensus Workshop participants.

J Clin Endocrinol Metab. 2008 Nov;93(11):4210-7. doi: 10.1210/jc.2008-0509. Epub 2008 Sep 9.

PMID:
18782877
33.

Absolute fracture risk.

Deal CL.

Curr Rheumatol Rep. 2007 Apr;9(1):66-70.

PMID:
17437670
34.

The United States rheumatology workforce: supply and demand, 2005-2025.

Deal CL, Hooker R, Harrington T, Birnbaum N, Hogan P, Bouchery E, Klein-Gitelman M, Barr W.

Arthritis Rheum. 2007 Mar;56(3):722-9.

35.

Normal minipuberty of infancy in boys with Prader-Willi syndrome.

Fillion M, Deal CL, Van Vliet G.

J Pediatr. 2006 Dec;149(6):874-6.

PMID:
17137911
37.

Genomic imprinting in Turner syndrome: effects on response to growth hormone and on risk of sensorineural hearing loss.

Hamelin CE, Anglin G, Quigley CA, Deal CL.

J Clin Endocrinol Metab. 2006 Aug;91(8):3002-10. Epub 2006 Jun 6.

PMID:
16757526
38.

Raloxifene: a selective estrogen-receptor modulator for postmenopausal osteoporosis - a clinical update on efficacy and safety.

Deal CL, Draper MW.

Womens Health (Lond). 2006 Mar;2(2):199-210. doi: 10.2217/17455057.2.2.199.

PMID:
19803890
39.

Tracing the origins of "fetal origins" of adult diseases: programming by oxidative stress?

Luo ZC, Fraser WD, Julien P, Deal CL, Audibert F, Smith GN, Xiong X, Walker M.

Med Hypotheses. 2006;66(1):38-44. Epub 2005 Sep 27.

PMID:
16198060
40.

Sudden death in growth hormone-treated children with Prader-Willi syndrome.

Van Vliet G, Deal CL, Crock PA, Robitaille Y, Oligny LL.

J Pediatr. 2004 Jan;144(1):129-31. Review.

PMID:
14722532
41.

Risedronate prevents hip fractures, but who should get therapy?

Deal CL.

Cleve Clin J Med. 2002 Dec;69(12):964, 968-70, 973-6. Review.

PMID:
12546269
42.

Using bone densitometry to monitor therapy in treating osteoporosis: pros and cons.

Deal CL.

Curr Rheumatol Rep. 2001 Jun;3(3):233-9. Review.

PMID:
11352792
43.

H19 sense and antisense transgenes modify insulin-like growth factor-II mRNA levels.

Wilkin F, Paquette J, Ledru E, Hamelin C, Pollak M, Deal CL.

Eur J Biochem. 2000 Jul;267(13):4020-7. Erratum in: Eur J Biochem 2000 Aug;267(15):4901. Mamelin C [corrected to Hamelin C].

44.

Human placental trophoblasts secrete a disintegrin metalloproteinase very similar to the insulin-like growth factor binding protein-3 protease in human pregnancy serum.

Irwin JC, Suen LF, Cheng BH, Martin R, Cannon P, Deal CL, Giudice LC.

Endocrinology. 2000 Feb;141(2):666-74.

PMID:
10650948
45.

Regulation of phosphatidylcholine homeostasis by calcium-independent phospholipase A2.

Barbour SE, Kapur A, Deal CL.

Biochim Biophys Acta. 1999 Jul 9;1439(1):77-88.

PMID:
10395967
46.
47.

Osteoporosis: prevention, diagnosis, and management.

Deal CL.

Am J Med. 1997 Jan 27;102(1A):35S-39S. Review.

PMID:
9217558
48.

Does growth-hormone supplementation affect adult height in Turner's syndrome?

Taback SP, Collu R, Deal CL, Guyda HJ, Salisbury S, Dean HJ, Van Vliet G.

Lancet. 1996 Jul 6;348(9019):25-7.

PMID:
8691926
49.

Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment.

Dubuis JM, Glorieux J, Richer F, Deal CL, Dussault JH, Van Vliet G.

J Clin Endocrinol Metab. 1996 Jan;81(1):222-7.

PMID:
8550756
50.

Supplemental Content

Support Center